Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-06-22Clinical Trial Update: Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy [Phase 1]
This Phase 1 clinical trial update reports the tolerance and biologic activity of oral ciclopirox olamine in patients with relapsed or refra…
-
CLINICAL_TRIALS trial_result · 2015-06-09Clinical Trial Update: A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion [Phase 2]
Phase 2 multicenter study evaluating ibrutinib in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma with 17p…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial of ofatumumab in patients with previously untreated chronic lymphocytic leukemia or small lymphocytic lymphoma has completed, …
-
CLINICAL_TRIALS trial_result · 2015-05-28Clinical Trial Update: Eltrombopag in Thrombocytopenic Chronic Lymphocytic Leukemia (CLL) Patients (CLL2S Study of GCLLSG) [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating eltrombopag for thrombocytopenia in chronic lymphocytic leukemia patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-05-12Clinical Trial Update: A Study of the Effect of Vinca Alkaloids on c-Jun N-terminal Kinase (JNK) Phosphorylation in Patients With Chronic Lymphocytic Leukemia (CLL) [EARLY_Phase 1]
An early-phase 1 trial evaluating the effect of vinca alkaloids on JNK phosphorylation in patients with chronic lymphocytic leukemia was ter…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-05-07Clinical Trial Update: Study of Hypoxia-Activated Prodrug TH-302 to Treat Advanced Leukemias [Phase 1]
Phase 1 study of TH-302 (evofosfamide), a hypoxia-activated prodrug, in patients with advanced leukemias has been completed, with evaluation…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: Bryostatin 1 and Rituximab in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial update of Bryostatin-1 in combination with Rituximab for patients with B-cell non-Hodgkin lymphoma or chronic lymphocytic leuk…
-
CLINICAL_TRIALS trial_result · 2015-04-30Clinical Trial Update: A Safety Confirmatory Study of Alemtuzumab in Japanese Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 1]
This report covers the completion of a Phase 1 safety confirmatory study of alemtuzumab in Japanese patients with relapsed or refractory chr…
-
CLINICAL_TRIALS trial_result · 2015-04-28Clinical Trial Update: Monoclonal Antibody Therapy in Treating Patients With Chronic Lymphocytic Leukemia [Phase 1]
A Phase 1 clinical trial evaluating a monoclonal antibody therapy for chronic lymphocytic leukemia has been completed.
-
CLINICAL_TRIALS trial_result · 2015-04-21Clinical Trial Update: Ofatumumab Maintenance Treatment vs No Further Treatment in Relapsed CLL Responding to Induction Therapy [Phase 3]
Phase 3 trial evaluating ofatumumab maintenance vs no further treatment in relapsed chronic lymphocytic leukemia after induction therapy; tr…
-
CLINICAL_TRIALS trial_result · 2015-04-20Clinical Trial Update: Phase 1 Weekly Dosing of SCH 727965 in Patients With Advanced Cancer (Study P04629AM6) [Phase 1]
Phase 1 update on weekly dosing of SCH 727965 in patients with advanced cancer, including solid tumors, non-Hodgkin lymphoma, multiple myelo…
-
CLINICAL_TRIALS trial_result · 2015-04-16Clinical Trial Update: Efficacy and Safety Study of PCI-32765 Combine With Ofatumumab in CLL [Phase 1, Phase 2]
Phase 1/2 trial results evaluate the efficacy and safety of combining ibrutinib (PCI-32765) with ofatumumab in B-cell chronic lymphocytic le…
-
CLINICAL_TRIALS trial_result · 2015-04-02Clinical Trial Update: Lenalidomide and Alvocidib in Treating Patients With Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
Phase 1 trial evaluating lenalidomide with alvocidib in relapsed or refractory B-cell chronic lymphocytic leukemia and small lymphocytic lym…
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Clofarabine in Chronic Lymphocytic Leukemia [Phase 1]
Phase 1 clinical trial update shows results for clofarabine in chronic lymphocytic leukemia; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2015-03-25Clinical Trial Update: Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL) [Phase 2]
Phase 2 study of talabostat with rituximab for advanced chronic lymphocytic leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Dasatinib in Treating Patients With Unresectable or Metastatic Squamous Cell Skin Cancer or RAI Stage 0-I Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 trial evaluating dasatinib for unresectable or metastatic squamous cell carcinoma of the skin and Rai stage 0-I chronic lymphocytic …
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Tolerance and Efficacy of Subcutanous Low Doses Rituximab for CLL Consolidation Treatment [Phase 2]
This Phase 2 trial update assesses the tolerance and efficacy of subcutaneous low-dose rituximab as consolidation therapy for chronic lympho…
-
CLINICAL_TRIALS trial_result · 2015-03-20Clinical Trial Update: Study of AMD3100 (Plerixafor) and Rituximab in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 1]
Phase 1 trial evaluating AMD3100 (Plerixafor) in combination with Rituximab in patients with chronic lymphocytic leukemia or small lymphocyt…
-
CLINICAL_TRIALS trial_result · 2015-03-13Clinical Trial Update: Trial of Bendamustine, Lenalidomide and Rituximab in Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin's Lymphoma (NHL) [Phase 1]
This is a phase 1 study of a triple-drug regimen (bendamustine, lenalidomide, and rituximab) in chronic lymphocytic leukemia and non-Hodgkin…
-
CLINICAL_TRIALS trial_result · 2015-03-09Clinical Trial Update: Haploid Allogeneic Transplant Using the CliniMACS System [Phase 2]
A Phase 2 clinical trial evaluating haploid allogeneic transplantation using the CliniMACS System was terminated, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-03-06Clinical Trial Update: First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers [Phase 1]
First-in-human Phase 1 trial assessing safety, tolerability, and preliminary efficacy of an anti-CXCR4 antibody in acute myeloid leukemia an…
-
CLINICAL_TRIALS trial_result · 2015-02-23Clinical Trial Update: Feasibility Study of a 60 Minute Rapid Infusion Rituximab Protocol in Patients With B-cell Malignancies [Phase 2]
A Phase 2 feasibility study evaluating a 60-minute rapid infusion rituximab protocol in patients with indolent or intermediate-grade B-cell …
-
CLINICAL_TRIALS trial_result · 2015-02-16Clinical Trial Update: A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia. [Phase 2]
Phase 2 trial evaluating MabThera (rituximab) plus chlorambucil in patients with previously untreated chronic lymphocytic leukemia; the stud…
-
CLINICAL_TRIALS trial_result · 2015-02-12Clinical Trial Update: Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT [Phase 2]
Phase 2 clinical trial evaluating reduced intensity total body irradiation plus Thymoglobulin followed by allogeneic peripheral blood stem c…
-
CLINICAL_TRIALS trial_result · 2015-02-11Clinical Trial Update: Pilot Study of Unrelated Cord Blood Transplantation [Phase 2]
Phase 2 pilot trial of unrelated cord blood transplantation sponsored by King's College Hospital NHS Trust has been terminated.